Document is current
Any future updates will be listed below
-
Authors
Welch, Charlie
Forster, Martin
Ronaldson, Sarah
Keding, Ada
Corbacho-MartÃn, Belen
Tharmanathan, Puvan
-
Funding
Funding for this research was provided by:
UK National Institute for Health Research (CTU Support Funding scheme (2019 call), CTU Support Funding scheme (2019 call))
UK National Institute for Health Research (CTU Support Funding scheme (2019 call), CTU Support Funding scheme (2019 call))
UK National Institute for Health Research (CTU Support Funding scheme (2019 call), CTU Support Funding scheme (2019 call))
- License Information
-
More Information
Article History
Received: 23 August 2023
Accepted: 17 May 2024
First Online: 19 July 2024
Declarations
:
: The HERO trial had research ethics committee approval from the Leeds East Research Ethics Committee and the UK Medicine and Healthcare Products Regulatory Agency. The trial was registered as ISRCTN91859104. All participants gave written informed consent before screening.
: Not applicable.
: The authors declare no competing interests.
